RPRX
Royalty Pharma plcNASDAQStock$49.74+0.35 (+0.72%)Mkt Cap 21.3BP/E 27.79Div Yield 1.81%Beta 0.39Vol 2.2MAvg Vol 2.8M
52W$32.11
$50.00
ETFs That Hold RPRX (Royalty Pharma plc)
1M
+7.07%
3M
+22.87%
6M
+34.41%
YTD
+27.77%
1Y
+52.58%
3Y
+40.53%
5Y
+12.08%
ETFs That Hold RPRX
Royalty Pharma plc is held by 185 ETFs. The largest position by market value is in VXF (Vanguard Extended Market ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| STXG | Strive 1000 Growth ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.01% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| GXLC | Global X - U.S. 500 ETF | 0.03% |
| CPI | IQ Real Return ETF | 0.01% |
Excludes leveraged and inverse ETFs.
PreviousPage 10 of 10
Frequently Asked Questions
How many ETFs hold RPRX?
Royalty Pharma plc (RPRX) is held by 185 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VXF (Vanguard Extended Market ETF).
What is the largest ETF that holds RPRX?
By fund size, VXF (Vanguard Extended Market ETF) with $81.60B in AUM holds 0.20% of its portfolio in RPRX, representing $169.1M in market value.
What percentage of IHE is RPRX?
RPRX makes up 4.85% of IHE (iShares U.S. Pharmaceuticals ETF), making it one of the largest positions in that fund.
Is RPRX in the S&P 500?
RPRX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.